Gabalex Capital Management LLC Bristol Myers Squibb CO Transaction History

Gabalex Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 03, 2021	SELL	$61.91 - $67.42 $3.71 Million - $4.05 Million	-60,000 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$59.34 - $66.74 $625,502 - $703,506	-10,541 Reduced 14.94%	60,000 $3.79 Million
Q4 2020 Feb 03, 2021	SELL	$57.74 - $65.43 $7.47 Million - $8.47 Million	-129,459 Reduced 64.73%	70,541 $4.38 Million
Q2 2020 Aug 04, 2020	SELL	$54.82 - $64.09 $1.37 Million - $1.6 Million	-25,000 Reduced 11.11%	200,000 $11.8 Million
Q1 2020 May 01, 2020	BUY	$46.4 - $67.43 $1.16 Million - $1.69 Million	25,000 Added 12.5%	225,000 $12.5 Million
Q3 2019 Nov 01, 2019	BUY	$42.77 - $50.71 $2.14 Million - $2.54 Million	50,000 Added 33.33%	200,000 $10.1 Million
Q2 2019 Aug 01, 2019	BUY	$44.62 - $49.34 $1.12 Million - $1.23 Million	25,000 Added 20.0%	150,000 $6.8 Million
Q1 2019 May 02, 2019	BUY	$45.12 - $53.8 $5.64 Million - $6.73 Million	125,000 New	125,000 $5.96 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Gabalex Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Gabalex Capital Management LLC with notifications on news.